TD Cowen Maintains Hold on 10x Genomics, Raises Price Target to $18

Benzinga · 4d ago
TD Cowen analyst Dan Brennan maintains 10x Genomics (NASDAQ:TXG) with a Hold and raises the price target from $15 to $18.